Profil bibliographique

Cathy Maxwell

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

18Publications signalées

491Citations signalées

3Affiliations récentes

Institutions déclarées

London School of Hygiene & Tropical Medicine Sierra Leone Urban Research Centre Janssen (Netherlands)

Domaines associés

Bone health and treatmentsNeutropenia and Cancer InfectionsManagement of metastatic bone diseaseOral health in cancer treatmentCancer Treatment and Pharmacology

Publications récentes

Accès ouvert 2021 articleOpenAlex

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno, Babajide Keshinro et autres

98 citationsThe Lancet Infectious Diseases

Accès ouvert 2021 articleOpenAlex

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi, Babajide Keshinro et autres

96 citationsThe Lancet Infectious Diseases

2020 articleOpenAlex

Safety and Accuracy of Active Breathing Coordinator Assisted Deep Inspiration Breathhold Technique in Delivery of Radiation Therapy for Locally Advanced Breast Cancer

D.N. Kim, Cathy Maxwell, Tor Chiu, A.S. Rahimi et autres

0 citationsInternational Journal of Radiation Oncology*Biology*Physics

2018 articleOpenAlex

A Randomized, Single-Blind Study Evaluating the Effect of a Bone Pain Education Video on Reported Bone Pain in Patients with Breast Cancer Receiving Chemotherapy and Pegfilgrastim

Andrew S Guinigundo, Cathy Maxwell, Linda Vanni, Phuong K. Morrow et autres

1 citationPain Management Nursing

Accès ouvert 2017 articleOpenAlex

NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim

Jeffrey J. Kirshner, Maxwell C. McDonald, Flavio Kruter, Andrew S Guinigundo et autres

41 citationsSupportive Care in Cancer

2016 conference-abstractOpenAlex

Nolan: A randomized, phase II study to estimate the effect of prophylactic naproxen (N) or loratadine (L) vs no intervention on bone pain in 600 patients (pts) with early-stage breast cancer receiving chemotherapy (chemo) and pegfilgrastim (PEG).

Jeffrey J. Kirshner, Andrew S Guinigundo, Linda Vanni, Cathy Maxwell et autres

2 citationsJournal of Clinical Oncology

2014 articleOpenAlex

Prevention and Treatment of Bone Loss in Patients With Nonmetastatic Breast or Prostate Cancer Who Receive Hormonal Ablation Therapy

Connie E. Limburg, Cathy Maxwell, Beatrice Mautner

3 citationsClinical journal of oncology nursing

2013 articleOpenAlex

Quality-of-Life Considerations With Taxane-Based Therapy in Metastatic Breast Cancer

Cathy Maxwell

5 citationsClinical journal of oncology nursing

2010 articleOpenAlex

Biomarker Research in Breast Cancer

Cathy Maxwell

6 citationsClinical journal of oncology nursing

2009 articleOpenAlex

Bone Metastases From Advanced Cancers

Margaret I. Fitch, Cathy Maxwell, Claire Ryan, Helen Löthman et autres

13 citationsClinical journal of oncology nursing

2008 articleOpenAlex

Bisphosphonate Therapy for Metastatic Bone Disease: The Pivotal Role of Nurses in Patient Education

Margaret I. Fitch, Cathy Maxwell

10 citationsOncology nursing forum

2008 articleOpenAlex

Putting Evidence Into Practice®: Evidence-Based Interventions for the Management of Oral Mucositis

Debra J. Harris, June Eilers, Amber Harriman, Barbara J. Cashavelly et autres

121 citationsClinical journal of oncology nursing

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.